Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,399 | 5,374 | 3,128 | 3,820 | 7,396 |
| Receivables | 2,527 | 2,232 | 2,898 | 2,572 | 2,407 |
| Inventories | 3,651 | 2,915 | 2,719 | 2,858 | 2,663 |
| Other current assets | 87 | 212 | 262 | 240 | 218 |
| TOTAL | $12,100 | $12,648 | $12,548 | $13,798 | $16,430 |
| Non-Current Assets | |||||
| PPE Net | 310 | 225 | 365 | 488 | 320 |
| Other Non-Current Assets | 1,550 | 820 | 1,827 | 1,945 | 2,095 |
| TOTAL | $1,860 | $1,045 | $2,192 | $2,433 | $2,415 |
| Total Assets | $13,960 | $13,693 | $14,740 | $16,231 | $18,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 431 | 808 |
| Accounts payable and accrued liabilities | 1,923 | 953 | 607 | 841 | 1,641 |
| Accrued Expenses | 2,252 | 2,224 | 2,113 | 2,029 | 1,843 |
| TOTAL | $4,832 | $4,096 | $3,719 | $3,717 | $5,819 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 284 | 641 | 478 | 160 | 1,277 |
| Other Non-Current Liabilities | 6,033 | 5,169 | 4,797 | 4,397 | 4,147 |
| TOTAL | $6,033 | $5,186 | $4,884 | $4,537 | $4,329 |
| Total Liabilities | $10,865 | $9,282 | $8,603 | $8,254 | $10,148 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,786 | 1,643 | 939 | 247 | 155 |
| Common Shares | N/A | N/A | N/A | 5 | 2 |
| Retained earnings | -200,981 | -197,806 | -194,349 | -189,514 | -184,363 |
| Other shareholders' equity | -3,243 | -4,376 | -2,723 | -3,418 | -4,312 |
| TOTAL | $3,095 | $4,411 | $6,137 | $7,977 | $8,697 |
| Total Liabilities And Equity | $13,960 | $13,693 | $14,740 | $16,231 | $18,845 |